{"title":"出现的问题:关于意大利国家卫生服务中nab-紫杉醇加吉西他滨与单独吉西他滨治疗转移性胰腺癌的成本效益。","authors":"Carlo Lazzaro","doi":"10.1186/s42506-024-00179-3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22819,"journal":{"name":"The Journal of the Egyptian Public Health Association","volume":"99 1","pages":"30"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11609134/pdf/","citationCount":"0","resultStr":"{\"title\":\"Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer.\",\"authors\":\"Carlo Lazzaro\",\"doi\":\"10.1186/s42506-024-00179-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":22819,\"journal\":{\"name\":\"The Journal of the Egyptian Public Health Association\",\"volume\":\"99 1\",\"pages\":\"30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11609134/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Egyptian Public Health Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s42506-024-00179-3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Egyptian Public Health Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42506-024-00179-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
Matters arising: On the cost-effectiveness for the Italian National Health Service of nab-paclitaxel plus gemcitabine vs gemcitabine alone in metastatic pancreatic cancer.
期刊介绍:
The journal accepts papers of original research which are not being considered for publication elsewhere and which contribute to the advancement of knowledge of Public Health at large